(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide

C29H35FN4O4 — CID 22771099

IUPAC(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide
SMILESCC(C)[C@@H](CC(=O)n1c2ccccc2c2ccccc21)C(=O)NC(CC(=O)N1CCN(C)CC1)C(=O)CF
InChIInChI=1S/C29H35FN4O4/c1-19(2)22(16-28(37)34-24-10-6-4-8-20(24)21-9-5-7-11-25(21)34)29(38)31-23(26(35)18-30)17-27(36)33-14-12-32(3)13-15-33/h4-11,19,22-23H,12-18H2,1-3H3,(H,31,38)/t22-,23?/m1/s1
InChIKeyJUKYOLMVZBKVIE-WTQRLHSKSA-N
MW522.62 g/mol
LogP3.28
Rot. Bonds9

About (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide

(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide (PubChem CID 22771099) has the molecular formula C29H35FN4O4 and a molecular weight of 522.62 g/mol. Its IUPAC name is (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide.

Molecular Properties

Compound Name(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide
PubChem CID22771099
Molecular FormulaC29H35FN4O4
Molecular Weight522.62 g/mol
Exact Mass522.26
IUPAC Name(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide
SMILESCC(C)[C@@H](CC(=O)n1c2ccccc2c2ccccc21)C(=O)NC(CC(=O)N1CCN(C)CC1)C(=O)CF
InChIInChI=1S/C29H35FN4O4/c1-19(2)22(16-28(37)34-24-10-6-4-8-20(24)21-9-5-7-11-25(21)34)29(38)31-23(26(35)18-30)17-27(36)33-14-12-32(3)13-15-33/h4-11,19,22-23H,12-18H2,1-3H3,(H,31,38)/t22-,23?/m1/s1
InChIKeyJUKYOLMVZBKVIE-WTQRLHSKSA-N
XLogP3.28
TPSA91.72 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500522.62
LogP ≤ 53.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide?
The IUPAC name of (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide (CID 22771099) is (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide.
What is the SMILES notation for (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide?
The canonical SMILES for (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide is CC(C)[C@@H](CC(=O)n1c2ccccc2c2ccccc21)C(=O)NC(CC(=O)N1CCN(C)CC1)C(=O)CF.
What is the InChIKey of (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide?
The InChIKey is JUKYOLMVZBKVIE-WTQRLHSKSA-N. The full InChI is InChI=1S/C29H35FN4O4/c1-19(2)22(16-28(37)34-24-10-6-4-8-20(24)21-9-5-7-11-25(21)34)29(38)31-23(26(35)18-30)17-27(36)33-14-12-32(3)13-15-33/h4-11,19,22-23H,12-18H2,1-3H3,(H,31,38)/t22-,23?/m1/s1.
What are the key properties of (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide?
(2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide has a molecular weight of 522.62 g/mol, XLogP of 3.28, 9 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-4-carbazol-9-yl-N-[5-fluoro-1-(4-methylpiperazin-1-yl)-1,4-dioxopentan-3-yl]-4-oxo-2-propan-2-ylbutanamide is sourced from PubChem (CID 22771099), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).